AIM Specialty Health® names Robert Mandel, MD, MBA, as chief medical officer
Chicago, IL, October 2, 2017 – AIM Specialty Health (AIM), a national leader in specialty benefits management, has named Robert Mandel, MD, MBA as chief medical officer. Mandel will help define and deliver strategies for health plans, providers, patients and employers working to improve the quality and value of healthcare.
Dr. Mandel brings extensive senior leadership experience in health systems, health plans, and innovative health service companies to his role as Chief Medical Officer for AIM. As part of the executive team, he will drive the clinical integrity of AIM solutions, lead the team of medical directors, and collaborate with clients on how to achieve better health outcomes while controlling costs.
"We are very pleased to have such an outstanding, respected leader with both industry and clinical practice experience join our team,"
"We are very pleased to have such an outstanding, respected leader with both industry and clinical practice experience join our team," said Brandon Cady, president and CEO of AIM. "Dr. Mandel's insights and perspectives from across the health care landscape will be invaluable to our client partners and staff. His appointment strengthens our ability to deliver solutions to our health plan clients that help their providers, members and customers focus on the value of their health decisions."
Most recently, Dr. Mandel served as President of Activate Healthcare, where he was responsible for opening new markets across the eastern United States, including sales, marketing, business development and operations. Prior to that, he served as president and CEO at Health Dialog, the wholly owned subsidiary of Rite Aid providing care management, health care analytics, decision support, and health coaching.
He has longtime experience with Blue Cross Blue Shield companies, serving as senior vice president of Health Care Services for BlueCross BlueShield of Tennessee where he was accountable for all the medical spend for the Commercial and Established Market Business Unit. Dr. Mandel also spent more than nine years with Blue Cross Blue Shield of Massachusetts where he held a number of VP roles, including health care services, e-health, provider enrollment and services, health care services administration and medical information, and was the senior medical director of provider partnerships.
Earlier in his career in Harrisburg, Pennsylvania, Dr. Mandel was a member of the initial leadership team of Health Central, a start-up, provider-sponsored HMO, and worked for Pinnacle Health System. He also is a practicing ophthalmologist who continues to see patients.
Dr. Mandel is a cum laude graduate of Princeton University and earned his Doctor of Medicine degree from The Johns Hopkins University School of Medicine. He also earned an MBA degree from the Wharton School at the University of Pennsylvania. He is a fellow of the American College of Surgeons and a member of the American Academy of Ophthalmology, the American College of Physician Executives, and the Massachusetts Medical Society.
AIM Specialty Health® provides clinical solutions that drive appropriate, safe, and affordable care. Serving more than 50 million members across 50 states, D.C. and US territories, AIM promotes optimal care through use of evidence-based clinical guidelines and real-time decision support for both providers and their patients. The AIM platform delivers significant cost-of-care savings across an expanding set of clinical domains including radiology, cardiology, oncology, specialty drugs, sleep medicine, musculoskeletal, pain management, and genetic testing. AIM is a wholly-owned subsidiary of Anthem, Inc. (ANTM). For more information, visit www.aimspecialtyhealth.com and www.aiminform.com.